TVRD · Company research
Tvardi Therapeutics, Inc. Common Stock (TVRD): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Registered investors can meet Tvardi's team in New York on Oct. 20. - Stock Titan | Registered investors can meet Tvardi's team in New York on Oct. 20. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| TVRD Oct 2026 5.000 call (TVRD261016C00005000) Stock Price, News, Quote & History - Yahoo! Finance Canada | TVRD Oct 2026 5.000 call (TVRD261016C00005000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 4, 2026 | neutral | 0 | 0.6 |
| Tvardi Therapeutics Inc (TVRD-Q) Stock Price and News - The Globe and Mail | Tvardi Therapeutics Inc (TVRD-Q) Stock Price and News The Globe and Mail | View source ↗ | The Globe and Mail | Sep 29, 2026 | neutral | 0 | 0.6 |
| Tvardi Therapeutics (NasdaqCM:TVRD) Stock Forecast & Analyst Predictions - Simply Wall Street | Tvardi Therapeutics (NasdaqCM:TVRD) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 27, 2026 | neutral | 0 | 0.6 |
| Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis - Slideshow - Seeking Alpha | Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis - Slideshow Seeking Alpha | View source ↗ | Seeking Alpha | Aug 19, 2026 | neutral | 0 | 0.6 |
| Tvardi Reports $6.5 Million Second-Quarter Net Loss and TTI-109 UC Plans | TVRD Stock News - Quiver Quantitative | Tvardi Reports $6.5 Million Second-Quarter Net Loss and TTI-109 UC Plans | TVRD Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 14, 2026 | neutral | 0 | 0.6 |
| Tvardi Therapeutics, Inc. Revenue Breakdown – NASDAQ:TVRD - TradingView | Tvardi Therapeutics, Inc. Revenue Breakdown – NASDAQ:TVRD TradingView | View source ↗ | TradingView | Aug 10, 2026 | neutral | 0 | 0.6 |
| TVRD Stock Rallies 149% So Far This Week: Here's What You Should Know - Yahoo Finance | TVRD Stock Rallies 149% So Far This Week: Here's What You Should Know Yahoo Finance | View source ↗ | Yahoo Finance | Jul 9, 2026 | neutral | 0 | 0.6 |
| Market Movers | Winners: CRNX, CLRO, TVRD | Losers: KIDZ, EDBL, WHLR - Trefis | Market Movers | Winners: CRNX, CLRO, TVRD | Losers: KIDZ, EDBL, WHLR Trefis | View source ↗ | Trefis | Jul 8, 2026 | neutral | 0 | 0.6 |
| Raymond James upgrades Tvardi Therapeutics stock rating on Phase 1 data - Investing.com | Raymond James upgrades Tvardi Therapeutics stock rating on Phase 1 data Investing.com | View source ↗ | Investing.com | Jul 8, 2026 | neutral | 0 | 0.6 |
| Wondering what's happening in today's after-hours session? - ChartMill | Wondering what's happening in today's after-hours session? ChartMill | View source ↗ | ChartMill | Jul 8, 2026 | neutral | 0 | 0.6 |
| Why Tvardi Therapeutics (TVRD) Stock Is Up Today - Quiver Quantitative | Why Tvardi Therapeutics (TVRD) Stock Is Up Today Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 7, 2026 | neutral | 0 | 0.6 |
| Tvardi says TTI-109 matched exposure, cut diarrhea in phase 1 - Stock Titan | Tvardi says TTI-109 matched exposure, cut diarrhea in phase 1 Stock Titan | View source ↗ | Stock Titan | Jul 7, 2026 | neutral | 0 | 0.6 |
| TVRD Forecast — Price Target — Prediction for 2027 - TradingView | TVRD Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Apr 17, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.